Ready Capital Valuation
Is RC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: RC ($7.2) is trading below our estimate of fair value ($8.64)
Significantly Below Fair Value: RC is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RC?
Key metric: As RC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is RC's PS Ratio? | |
|---|---|
| PS Ratio | 8.6x |
| Sales | US$140.36m |
| Market Cap | US$1.23b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does RC's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 8x | ||
CIM Chimera Investment | 2.7x | -10.1% | US$1.2b |
ARI Apollo Commercial Real Estate Finance | 7.8x | 3.5% | US$1.3b |
DX Dynex Capital | 11.6x | -45.5% | US$1.4b |
TWO Two Harbors Investment | 9.9x | -56.8% | US$1.2b |
RC Ready Capital | 8.6x | 36.4% | US$1.2b |
Price-To-Sales vs Peers: RC is expensive based on its Price-To-Sales Ratio (8.6x) compared to the peer average (8x).
Price to Sales Ratio vs Industry
How does RC's PS Ratio compare vs other companies in the US Mortgage REITs Industry?
| 1 Company | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
BMNM Bimini Capital Management | 0.7x | n/a | US$9.54m |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: RC is expensive based on its Price-To-Sales Ratio (8.6x) compared to the US Mortgage REITs industry average (5.4x).
Price to Sales Ratio vs Fair Ratio
What is RC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 8.6x |
| Fair PS Ratio | 3x |
Price-To-Sales vs Fair Ratio: RC is expensive based on its Price-To-Sales Ratio (8.6x) compared to the estimated Fair Price-To-Sales Ratio (3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$7.20 | US$8.79 +22.1% | 20.9% | US$12.00 | US$6.75 | n/a | 6 |
| Nov ’25 | US$6.75 | US$9.00 +33.3% | 19.0% | US$12.00 | US$7.00 | n/a | 6 |
| Oct ’25 | US$7.44 | US$9.29 +24.9% | 16.2% | US$12.00 | US$7.75 | n/a | 6 |
| Sep ’25 | US$8.29 | US$9.54 +15.1% | 14.5% | US$12.00 | US$7.75 | n/a | 6 |
| Aug ’25 | US$9.12 | US$9.67 +6.0% | 14.5% | US$12.00 | US$8.00 | n/a | 6 |
| Jul ’25 | US$8.11 | US$9.83 +21.2% | 16.3% | US$12.00 | US$8.00 | n/a | 6 |
| Jun ’25 | US$8.30 | US$10.00 +20.5% | 15.0% | US$12.00 | US$8.00 | n/a | 6 |
| May ’25 | US$8.67 | US$10.21 +17.8% | 13.0% | US$12.00 | US$8.00 | n/a | 7 |
| Apr ’25 | US$8.96 | US$10.44 +16.5% | 13.2% | US$12.00 | US$8.00 | n/a | 8 |
| Mar ’25 | US$8.97 | US$11.06 +23.3% | 10.0% | US$13.00 | US$9.50 | n/a | 8 |
| Feb ’25 | US$9.50 | US$11.69 +23.0% | 10.7% | US$14.00 | US$10.00 | n/a | 8 |
| Jan ’25 | US$10.25 | US$11.69 +14.0% | 10.7% | US$14.00 | US$10.00 | n/a | 8 |
| Dec ’24 | US$10.50 | US$11.81 +12.5% | 10.4% | US$14.00 | US$10.00 | n/a | 8 |
| Nov ’24 | US$9.51 | US$12.06 +26.8% | 10.5% | US$14.00 | US$10.50 | US$6.75 | 8 |
| Oct ’24 | US$10.11 | US$12.56 +24.3% | 10.6% | US$14.50 | US$10.50 | US$7.44 | 8 |
| Sep ’24 | US$11.00 | US$12.56 +14.2% | 10.6% | US$14.50 | US$10.50 | US$8.29 | 8 |
| Aug ’24 | US$11.31 | US$12.81 +13.3% | 11.5% | US$15.00 | US$10.50 | US$9.12 | 8 |
| Jul ’24 | US$11.28 | US$12.63 +11.9% | 13.1% | US$15.00 | US$10.50 | US$8.11 | 8 |
| Jun ’24 | US$9.93 | US$12.63 +27.1% | 13.1% | US$15.00 | US$10.50 | US$8.30 | 8 |
| May ’24 | US$10.50 | US$12.94 +23.2% | 12.6% | US$15.00 | US$10.50 | US$8.67 | 8 |
| Apr ’24 | US$10.17 | US$13.69 +34.6% | 10.8% | US$16.00 | US$11.50 | US$8.96 | 8 |
| Mar ’24 | US$11.05 | US$13.88 +25.6% | 9.8% | US$16.00 | US$11.50 | US$8.97 | 8 |
| Feb ’24 | US$13.35 | US$14.13 +5.8% | 10.4% | US$16.00 | US$11.50 | US$9.50 | 8 |
| Jan ’24 | US$11.14 | US$14.25 +27.9% | 10.8% | US$16.00 | US$11.50 | US$10.25 | 8 |
| Dec ’23 | US$13.42 | US$14.31 +6.7% | 11.2% | US$16.00 | US$11.00 | US$10.50 | 8 |
| Nov ’23 | US$11.98 | US$14.56 +21.6% | 16.5% | US$18.50 | US$11.00 | US$9.51 | 8 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Ameriprise Financial
US$54.6b
Provides various financial products and services to individual and institutional clients in the United States and internationally.
AMP
US$562.56
7D
0.5%
1Y
60.5%
Investor
SEK 905.1b
A private equity firm specializing in mature, middle market, buyouts and growth capital investments.
IVSB.F
SEK 26.69
7D
-4.0%
1Y
32.1%
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
IX
JP¥108.58
7D
0.8%
1Y
19.5%